The European Food Safety Authority (EFSA) has opened a public consultation on its draft guidance for the risk assessment of nanoscience and nanotechnology applications in the food and feed chain.
Feed additive producer, Nutriad, which operates four laboratories and five plants located in Belgium, Spain, the UK, China and the US, has been bought by Chinese group, Adisseo.
We talk to Juan Antonio Mesonero Escuredo, global program manager for swine gut health at Trouw Nutrition, to hear about his working life in a career spanning two decades. We also gauge his perspective on industry challenges.
A new EU functional group of feed additives is required to incentivize the industry to invest in products to support animal health and welfare, says a Belgian Ministry of Health representative.
EFSA has launched a public consultation on its draft guidance document on the characterization of microorganisms used as feed additives or as production organisms.
EFSA is inviting industry representatives to join two ad-hoc discussion groups that will assist in the development of draft guidance documents on the assessment of feed additives.
The effect of nutrition on animal health is scientifically evident and communication and progress should not be blocked by regulations, argues a leading light of the feed industry.
Belgian headquartered, Nutriad, says new trial work carried out by it in conjunction with leading Vietnamese aquaculture researchers indicates functional feed additives - probiotics, organic acids, yeast extracts and phytobiotics – play a key role in...
EFSA has looked to external experts in data collection to help it as it takes on the somewhat byzantine task of botanically derived feed additive risk assessment.
Exploiting the potential of bacteria to produce natural feed additives is the aim of a new partnership between two French companies - animal nutrition and agribusiness group, Sofiproteol, and biotechnology firm, Deinove.
There are a limited number of nanomaterials in development for feed additives, but projects with some momentum behind them include one looking to replace antibiotics with nano-sized substitutes, finds an EFSA-commissioned report.
